CRISPR Therapeutics AG (CRSP)
49.39
-0.60
(-1.20%)
USD |
NASDAQ |
Oct 23, 16:00
49.07
-0.32
(-0.65%)
After-Hours: 20:00
CRISPR Therapeutics Enterprise Value : 3.193B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.193B |
| October 22, 2026 | 3.251B |
| October 21, 2026 | 3.300B |
| October 20, 2026 | 3.240B |
| October 19, 2026 | 3.256B |
| October 16, 2026 | 3.180B |
| October 15, 2026 | 3.399B |
| October 14, 2026 | 3.273B |
| October 13, 2026 | 3.262B |
| October 12, 2026 | 3.402B |
| October 09, 2026 | 3.580B |
| October 08, 2026 | 3.295B |
| October 07, 2026 | 3.479B |
| October 06, 2026 | 3.639B |
| October 05, 2026 | 3.962B |
| October 02, 2026 | 3.777B |
| October 01, 2026 | 3.778B |
| September 30, 2026 | 3.766B |
| September 29, 2026 | 3.832B |
| September 28, 2026 | 3.647B |
| September 25, 2026 | 3.661B |
| September 24, 2026 | 3.803B |
| September 23, 2026 | 3.809B |
| September 22, 2026 | 4.125B |
| September 21, 2026 | 4.057B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.886B |
| September 17, 2026 | 3.960B |
| September 16, 2026 | 3.466B |
| September 15, 2026 | 3.429B |
| September 14, 2026 | 3.538B |
| September 11, 2026 | 3.418B |
| September 10, 2026 | 3.471B |
| September 09, 2026 | 3.586B |
| September 08, 2026 | 3.714B |
| September 04, 2026 | 3.812B |
| September 03, 2026 | 3.879B |
| September 02, 2026 | 3.921B |
| September 01, 2026 | 3.911B |
| August 31, 2026 | 3.927B |
| August 28, 2026 | 3.998B |
| August 27, 2026 | 4.158B |
| August 26, 2026 | 4.144B |
| August 25, 2026 | 4.306B |
| August 24, 2026 | 3.936B |
| August 21, 2026 | 4.170B |
| August 20, 2026 | 4.037B |
| August 19, 2026 | 4.200B |
| August 18, 2026 | 3.539B |
| August 17, 2026 | 3.666B |
| August 14, 2026 | 3.595B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Net Income (Quarterly) | -91.15M |
| Revenue (Quarterly) | 10.18M |
| Total Expenses (Quarterly) | 101.34M |
| EPS Diluted (Quarterly) | -0.9445 |
| Gross Profit Margin (Quarterly) | -337.8% |
| Profit Margin (Quarterly) | -895.3% |
| Earnings Yield | -9.64% |
| Normalized Earnings Yield | -9.685 |